Sarah Boyce - Insider Trading & Ownership

Entity
Individual
Location
C/O Ionis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad, California
Summary
The estimated net worth of Sarah Boyce is at least $3.59M dollars as of May 7, 2024. Sarah Boyce is the President and CEO, Director of Avidity Biosciences, Inc. and owns shares of Avidity Biosciences, Inc. (RNA) worth about $2.86M. Sarah Boyce is the Director of OmniAb, Inc. and owns shares of OmniAb, Inc. (OABI) worth about $514K. Sarah Boyce is the Former Director of LIGAND PHARMACEUTICALS INC and owns shares of LIGAND PHARMACEUTICALS INC (LGND) worth about $209K. Sarah Boyce is the Director of Berkeley Lights, Inc. and owns shares of Bruker Cellular Analysis, Inc. worth about $770.
All Insider Reports
All Insider Reports

Ownership of Sarah Boyce

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RNA Avidity Biosciences, Inc. President and CEO, Director $2.86M -$5.62M -66.3% May 7, 2024
OABI, OABIW OmniAb, Inc. Director $514K Jun 23, 2023
LGND, LGNDZ LIGAND PHARMACEUTICALS INC Former Director $209K Nov 1, 2022
Bruker Cellular Analysis, Inc. Director $770 May 14, 2021

Insider Transactions Reported by Sarah Boyce:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership